Detalles de la búsqueda
1.
Safety, Tolerability, and Immunogenicity of aH5N1 Vaccine in Adults with and without Underlying Medical Conditions.
Vaccines (Basel)
; 12(5)2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793732
2.
Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation.
Int Arch Allergy Immunol
; 160(4): 420-4, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23183541
3.
Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture-derived H5N1 (aH5n1c) influenza vaccine in adults and older adults.
Hum Vaccin Immunother
; 19(1): 2193119, 2023 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057755
4.
Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects.
Vaccines (Basel)
; 10(4)2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35455245
5.
Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
Vaccine
; 39(47): 6930-6935, 2021 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34711436
6.
Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults.
Vaccines (Basel)
; 9(12)2021 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34960214
7.
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.
Clin Transl Allergy
; 4: 23, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25097754
Resultados
1 -
7
de 7
1
Próxima >
>>